{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:17:59Z","timestamp":1780330679406,"version":"3.54.1"},"reference-count":25,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3960\/jslrt.55.157","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T01:08:04Z","timestamp":1452647284000},"page":"157-161","source":"Crossref","is-referenced-by-count":12,"title":["Intraocular Relapse with Hypopyon and Retinal Infiltrates after Chemotherapy and Peripheral Blood Stem Cell Transplantation for Extranodal NK\/T-Cell Lymphoma"],"prefix":"10.3960","volume":"55","author":[{"given":"Toshihiko","family":"Matsuo","sequence":"first","affiliation":[{"name":"Departments of Ophthalmology, Okayama University Hospital and Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Okayama University Hospital and Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Ichimura","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Okayama University Hospital and Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Meguri","sequence":"additional","affiliation":[{"name":"Departments of Hematology\/Oncology, Okayama University Hospital and Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Lobo A, Larkin G, Clark BJ, Towler HMA, Lightman S: Pseudo-hypopyon as the presenting feature in B-cell and T-cell intraocular lymphoma. Clin Exp Ophthalmol 31:155-158, 2003","DOI":"10.1046\/j.1442-9071.2003.00624.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Papaliodis GN, Montezuma SR: Pseudo-hypopyon as the presenting feature of recurrent B-cell lymphoma. Ocul Immunol Inflamm 16:121-122, 2008","DOI":"10.1080\/09273940802026052"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Matsuo T, Ichimura K, Ichikawa T, Okumura Y, Kaji M, <i>et al<\/i>.: Positron emission tomography\/computed tomography after immunocytochemical and clonal diagnosis of intraocular lymphoma with vitrectomy cell blocks. J Clin Exp Hematop 49:77-87, 2009","DOI":"10.3960\/jslrt.49.77"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Dorrepaal SJ, Margolin EA, Wang C: Bilateral pseudohypopyon as a presenting feature of recurrent diffuse large B-cell lymphoma. J Neuroophthalmol 30:67-69, 2010","DOI":"10.1097\/WNO.0b013e3181ce2c98"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ayliffe W, Foster CS, Marcoux P, Upton M, Finkelstein M, <i>et al<\/i>.: Relapsing acute myeloid leukemia manifesting as hypopyon uveitis. Am J Ophthalmol 119:361-364, 1995","DOI":"10.1016\/S0002-9394(14)71181-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Matano S, Ohta T, Nakamura S, Kanno M, Sugimoto T: Leukemic hypopyon in acute myelogenous leukemia. Ann Hematol 79:455-458, 2000","DOI":"10.1007\/s002770000164"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Yi DH, Rashid S, Cibas ES, Arrigg PG, Dana MR: Acute unilateral leukemic hypopyon in an adult with relapsing acute lymphoblastic leukemia. Am J Ophthalmol 139:719-721, 2005","DOI":"10.1016\/j.ajo.2004.09.074"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Aozasa K, Takakuwa T, Hongyo T, Yang WI: Nasal NK\/T-cell lymphoma: Epidemiology and pathogenesis. Int J Hematol 87:110-117, 2008","DOI":"10.1007\/s12185-008-0021-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Liang R: Advances in the management and monitoring of extranodal NK\/T-cell lymphoma, nasal type. Br J Hematol 147:13-21, 2009","DOI":"10.1111\/j.1365-2141.2009.07802.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kwong YL: The diagnosis and management of extranodal NK\/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia. J Clin Exp Hematop 51:21-28, 2011","DOI":"10.3960\/jslrt.51.21"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, <i>et al<\/i>.: Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia. Cancer Sci 99:1016-1020, 2008","DOI":"10.1111\/j.1349-7006.2008.00768.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Murashige N, Kami M, Kishi Y, Kim SW, Takeuchi M, <i>et al<\/i>.: Allogeneic hematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Hematol 130:561-567, 2005","DOI":"10.1111\/j.1365-2141.2005.05651.x"},{"key":"13","unstructured":"13 Lee J, Au WY, Park MJ, Suzumiya J, Nakamura S, <i>et al<\/i>.: Autologous hematopoietic stem cell transplantation in extranodal natural killer\/T cell lymphoma: A multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 14:1356-1364, 2008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Mori Y, Aoki T, Takenaka K, Yamauchi T, Yamamoto A, <i>et al<\/i>.: Successful treatment of refractory advanced nasal NK\/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation. Int J Hematol 91:107-111, 2010","DOI":"10.1007\/s12185-009-0453-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Matsuo T, Ichimura K, Shinagawa K: Orbital MALT lymphoma, abdominal Hodgkin lymphoma, and systemic diffuse large B-cell lymphoma develop sequentially in one patient. J Clin Exp Hematop 52:41-49, 2012","DOI":"10.3960\/jslrt.52.41"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Matsuo T, Ichimura K, Okada H, Shinagawa K, Fukushima K, <i>et al<\/i>.: Clonal analysis of bilateral, recurrent, or systemically multifocal ocular adnexal lymphoma. J Clin Exp Hematop 50:27-38, 2010","DOI":"10.3960\/jslrt.50.27"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Matsuo T, Ichimura K: Immunocytochemical diagnosis as inflammation by vitrectomy cell blocks in patients with vitreous opacity. Ophthalmology 119:827-837, 2012","DOI":"10.1016\/j.ophtha.2011.10.020"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Hon C, Kwok AKH, Shek TWH, Chim JCS, Au WY: Vision-threatening complications of nasal T\/NK lymphoma. Am J Ophthalmol 134:406-410, 2002","DOI":"10.1016\/S0002-9394(02)01520-9"},{"key":"19","unstructured":"19 Ely A, Evans J, Sundstrom JM, Malysz J, Specht CS, <i>et al<\/i>.: Orbital involvement in extranodal natural killer T cell lymphoma: An atypical case presentation and review of the literature. Orbit 31:267-269, 2012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Kase S, Namba K, Kitaichi N, Ohno S: Epstein-Barr virus infected cells in the aqueous humor originated from nasal NK\/T cell lymphoma. Br J Ophthalmol 90:244-245, 2006","DOI":"10.1136\/bjo.2005.081885"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Cimino L, Chan CC, Shen D, Masini L, Llariucci F, <i>et al<\/i>.: Ocular involvement in nasal natural killer T-cell lymphoma. Int Ophthalmol 29:275-279, 2009","DOI":"10.1007\/s10792-008-9220-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Lee EJ, Kim TW, Heo JW, Yu HG, Chung H: Natural killer\/T-cell lymphoma of nasal type with intraocular involvement: Case report. Eur J Ophthalmol 20:215-217, 2010","DOI":"10.1177\/112067211002000130"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Hill QA, Owen RG: CNS prophylaxis in lymphoma: Who to target and what therapy to use. Blood Rev 20:319-332, 2006","DOI":"10.1016\/j.blre.2006.02.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, <i>et al<\/i>.: Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109:1709-1716, 2002","DOI":"10.1016\/S0161-6420(02)01125-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Frenkel S, Hendler K, Siegal T, Shalom E, Pe&apos;er J: Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol 92:383-388, 2008","DOI":"10.1136\/bjo.2007.127928"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/55\/3\/55_157\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T14:31:13Z","timestamp":1567521073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/55\/3\/55_157\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.55.157","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}